Landscapes, Genomics and Transgenic Conifers

Hardcover  VIII, 261 p.  ISBN 1402038682      £66.00

The book is written for policy experts, life scientists, government and business leaders, biotechnology writers and activists. Few decision-makers realize the unprecedented degree to which transgenic technology is now possible for forests on a commercial scale. Only a handful of the 550 living conifer species is used for commodity value and even fewer species are being developed for transgenic plantations. Transgenic field trials started within the last decade but no transgenic pine plantations exist in 2005. But emergence of transgenic forest trees is still so recent that dialogue about the pros and cons is confined to the scientific community. And dialogue must move out into the public domain.

So little opportunity remains for opening public dialogue. The pursuit of transgenic research for forest trees is principally corporate so novel forest tree phenotypes are created as a means to increase shareholder value for investor companies. And while potential benefits will accrue to shareholders, ecological risks for certain transgenic traits are likely to be shared due to long-distance gene flow and inadequate bioconfinement measures. So this is a question riddled with tension. Without public deliberation, we should expect alienation of several interest groups. Alienation will lead to heightened clashes in the public policy arena or even radical environmental action. But how to move dialogue on transgenic forests forward? One must re-frame the issues behind transgenic conifer plantations.

The goal of this volume is to provide content for public deliberations about the genetic composition of future forests. Its Section I is composed of provocative and opposing views on the question of transgenic conifer plantations. Sections II and III follow with research advances on relevant conifer genomics and ecology research, respectively. Section IV forecasts rates of technology adoption for different case studies. Finally, Section V compares the status of regulatory oversight of transgenic forest trees between Canada and the United States. But will the book fulfil its goal? The burden of the answer lies with its readers. Will readers act € or will transgenic forests be seen as too remote or simply too rural to bother with the angst of public deliberation?

Written for: R&D/technology policymakers, biotechnology firm investment due-diligence experts, conservation leadership, natural resource leadership, natural resources, ecology and conservation university administration, forest management economists, international trade experts, forestry extension, environmental non-governmental organizations, political aides, government regulatory agencies

Contents

Introduction; C.G. Williams. Section I: Pros and Cons for Transgenic Conifer Plantations.

• Foresters and DNA; J. Ausubel et al.
• Questioning Commercial Use of Transgenic Conifers; C.G. Williams.
• It€s Just A Crop: Public Perception and Transgenic Trees; S. Anderson.

• Genomics Resources for Conifers; J. Dean.
• A New Direction for Conifer Genomics; K. Ritland et al.
• Using Genomics to Study Evolutionary Origins of Seeds; E. Brenner, D. Stevenson.
• Metabolic Profiling for Transgenic Forest Trees; H. Häggmann, R. Julkunen-Tiitto.

• Dispersal of Transgenic Conifer Pollen; G. Katul et al. Gene Flow in Conifers; J. Mitton, C.G. Williams. Pines as Invasive Aliens: Outlook for Transgenic Conifers in the Southern Hemisphere; D. Richardson, R. Petit.

• Economic Prospects and Policy Framework for Forest Biotechnology for the Southern United States and South America; F. Cubbage et al. Transgenic Forest Trees and Private Forests; M. Megalos.

• Canada€s Regulatory Approach; A.-C. Bonfils.
• Biosafety of Transgenic Forests in the United States; R. Irwin, P. Jones.